美国 · SEC FORM 4
ANI PHARMACEUTICALS INC
ANIP · Nasdaq · CIK 0001023024 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
32 同一窗口内观察到的 Form 4 交易行
23 sales · 9 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-03-21 · Lalwani Nikhil.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -1.2%
- 3M
- -15.1%
- 6M
- -2.7%
- 12M
- —
波动率与流动性
- 波动率
- 31.4%
- Beta
- 0.45
- 平均每日成交额
- USD 26.6M
估值
- 市值
- USD 1.7B
- P/E
- 15.7×
基本面
- 利润率
- 8.8%
- ROE
- 14.4%
- 细分行业
- Drug Manufacturers—Specialty & Generic
市场数据
价格数据截至：2026-10-03 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · 来自 Yahoo Finance：市值, P/E · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,491,281
- 上期报告
- 2,490,166
- 日均成交量
- 487,356
- 回补天数
- 7.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-03-21 | Lalwani Nikhil | 买入 (P) | Common Stock | 7,224 | USD 27.69 | USD 200,033 | SEC 申报 ↗ |
| 2022-03-21 | Walsh Patrick D | 买入 (P) | Common Stock | 5,000 | USD 27.76 | USD 138,800 | SEC 申报 ↗ |
| 2022-03-21 | Gassert Chad | 买入 (P) | Common Stock | 5,000 | USD 27.87 | USD 139,350 | SEC 申报 ↗ |
| 2022-03-18 | Gassert Chad | 买入 (P) | Common Stock | 5,000 | USD 27.15 | USD 135,750 | SEC 申报 ↗ |
| 2022-03-17 | Shanmugam Muthusamy | 买入 (P) | Common Stock | 5,000 | USD 27.65 | USD 138,250 | SEC 申报 ↗ |
| 2021-12-20 | Thoma Jeanne | 买入 (P) | Common Stock | 1,072 | USD 46.47 | USD 49,816 | SEC 申报 ↗ |
| 2021-12-07 | Pera Antonio R | 买入 (P) | Common Stock | 3,000 | USD 42.26 | USD 126,780 | SEC 申报 ↗ |
| 2021-12-06 | HAUGHEY THOMAS | 买入 (P) | Common Stock | 2,500 | USD 39.38 | USD 98,450 | SEC 申报 ↗ |
| 2021-03-16 | Thoma Jeanne | 买入 (P) | Common Stock | 1,500 | USD 33.22 | USD 49,830 | SEC 申报 ↗ |
| 2021-03-15 | Walsh Patrick D | 买入 (P) | Common Stock | 4,000 | USD 32.89 | USD 131,560 | SEC 申报 ↗ |
| 2020-11-09 | Walsh Patrick D | 买入 (P) | Common Stock | 5,000 | USD 25.96 | USD 129,800 | SEC 申报 ↗ |
| 2020-08-10 | Walsh Patrick D | 买入 (P) | Common Stock | 10,000 | USD 30.78 | USD 307,790 | SEC 申报 ↗ |
| 2020-03-04 | HAUGHEY THOMAS | 买入 (P) | Common Stock | 3,000 | USD 45.05 | USD 135,150 | SEC 申报 ↗ |
| 2020-03-03 | HAUGHEY THOMAS | 买入 (P) | Common Stock | 2,000 | USD 45.18 | USD 90,360 | SEC 申报 ↗ |
Form 4 申报证据
106 transaction lines in the latest 365-day window; 507 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Lalwani Nikhil | 卖出 (S) | Common Stock | 5,400 | USD 71.89 | USD 388,206 | SEC 申报 ↗ |
| 2026-10-13 | Cook Meredith | 卖出 (S) | Common Stock | 500 | USD 73.59 | USD 36,795 | SEC 申报 ↗ |
| 2026-09-29 | CAREY STEPHEN P. | 卖出 (S) | Common Stock | 2,850 | USD 73.00 | USD 208,050 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Lalwani Nikhil | 卖出 (S) | Common Stock | 5,400 | USD 71.89 | USD 388,206 | SEC 申报 ↗ |
| 2026-10-13 | Cook Meredith | 卖出 (S) | Common Stock | 500 | USD 73.59 | USD 36,795 | SEC 申报 ↗ |
| 2026-09-29 | CAREY STEPHEN P. | 卖出 (S) | Common Stock | 2,850 | USD 73.00 | USD 208,050 | SEC 申报 ↗ |
| 2026-09-15 | Lalwani Nikhil | 卖出 (S) | Common Stock | 5,400 | USD 71.00 | USD 383,400 | SEC 申报 ↗ |
| 2026-09-14 | Cook Meredith | 卖出 (S) | Common Stock | 500 | USD 70.79 | USD 35,395 | SEC 申报 ↗ |
| 2026-09-11 | Thoma Jeanne | 卖出 (S) | Common Stock | 1,000 | USD 71.53 | USD 71,530 | SEC 申报 ↗ |
| 2026-08-31 | CAREY STEPHEN P. | 卖出 (S) | Common Stock | 2,850 | USD 72.80 | USD 207,480 | SEC 申报 ↗ |
| 2026-08-25 | Lalwani Nikhil | 卖出 (S) | Common Stock | 5,400 | USD 74.30 | USD 401,220 | SEC 申报 ↗ |
| 2026-08-19 | Gosebruch Henry O | 奖励／授予 (A) | Common Stock | 6,662 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-13 | Cook Meredith | 卖出 (S) | Common Stock | 500 | USD 75.48 | USD 37,740 | SEC 申报 ↗ |
| 2026-08-10 | Gutwerg Ori | 卖出 (S) | Common Stock | 3,162 | USD 77.00 | USD 243,474 | SEC 申报 ↗ |
| 2026-07-29 | CAREY STEPHEN P. | 卖出 (S) | Common Stock | 2,850 | USD 81.36 | USD 231,876 | SEC 申报 ↗ |
| 2026-07-18 | Cook Meredith | 代扣税 (F) | Common Stock | 2,466 | USD 79.20 | USD 195,307 | SEC 申报 ↗ |
| 2026-07-13 | Cook Meredith | 卖出 (S) | Common Stock | 500 | USD 81.84 | USD 40,920 | SEC 申报 ↗ |
| 2026-07-02 | CAREY STEPHEN P. | 卖出 (S) | Common Stock | 3,313 | USD 86.00 | USD 284,918 | SEC 申报 ↗ |
| 2026-07-02 | CAREY STEPHEN P. | 期权行权／转换 (M) | Common Stock | 3,313 | USD 49.51 | USD 164,027 | SEC 申报 ↗ |
| 2026-06-29 | CAREY STEPHEN P. | 卖出 (S) | Common Stock | 2,850 | USD 84.12 | USD 239,742 | SEC 申报 ↗ |
| 2026-06-12 | Cook Meredith | 卖出 (S) | Common Stock | 500 | USD 82.03 | USD 41,015 | SEC 申报 ↗ |
| 2026-06-08 | HAUGHEY THOMAS | 卖出 (S) | Common Stock | 2,000 | USD 80.88 | USD 161,760 | SEC 申报 ↗ |
| 2026-06-05 | CAREY STEPHEN P. | 卖出 (S) | Common Stock | 3,312 | USD 80.00 | USD 264,960 | SEC 申报 ↗ |
| 2026-06-05 | CAREY STEPHEN P. | 期权行权／转换 (M) | Common Stock | 3,312 | USD 49.51 | USD 163,977 | SEC 申报 ↗ |
| 2026-05-21 | Thoma Jeanne | 奖励／授予 (A) | Common Stock | 4,357 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | TANNENBAUM RENEE P | 奖励／授予 (A) | Common Stock | 4,357 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Pera Antonio R | 奖励／授予 (A) | Common Stock | 4,357 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Leonard Matthew J | 奖励／授予 (A) | Common Stock | 4,357 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | HAUGHEY THOMAS | 奖励／授予 (A) | Common Stock | 4,357 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-13 | Walsh Patrick D | 卖出 (S) | Common Stock | 10,000 | USD 80.63 | USD 806,300 | SEC 申报 ↗ |
| 2026-05-13 | Cook Meredith | 卖出 (S) | Common Stock | 500 | USD 78.16 | USD 39,080 | SEC 申报 ↗ |
| 2026-05-12 | Rowland Thomas Andrew | 卖出 (S) | Common Stock | 459 | USD 79.21 | USD 36,357 | SEC 申报 ↗ |
| 2026-05-12 | Gutwerg Ori | 卖出 (S) | Common Stock | 2,772 | USD 79.50 | USD 220,374 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ANIP |
| CIK | 0001023024 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 507 transaction lines from 2020-03-03 to 2026-10-15 16 P purchase lines · 201 S sale lines · 290 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.